vimarsana.com
Home
Live Updates
TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors : vimarsana.com
TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors : vimarsana.com
TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors
DENVER--(BUSINESS WIRE)--Feb 29, 2024--
Related Keywords
United States ,
Mary Szela ,
Trinav Smartvalve ,
Stevenc Katz ,
Centers For Medicare ,
Current Medical Research ,
Nasdaq ,
Linkedin ,
Twitter ,
Trisalus Life Sciences ,
Salus Life Sciences ,
Chief Executive Officer ,
Healthcare Common Procedure Coding System ,
Chief Medical Officer ,
Trinav Infusion ,
Pressure Enabled Drug Delivery ,
Transcatheter Arterial Chemoembolization ,
Transcatheter Arterial Radioembolization ,
Infusion System ,
Pancreatic Retrograde Venous Infusion System ,
Pressure Enabled Regional Immuno Oncology ,
For Media ,
Investor Inquiries ,
Trisalus Life ,
Business Wire ,
Region ,